Chandigarh [India], April 17: Healing Hospital Chandigarh today announced the launch of Adaptive Deep Brain Stimulation (aDBS), an advanced therapy for Parkinson’s disease. With this development, the ...

The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...

Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...

This video is no longer available. Rick Schena, of Alexandria, Virginia, and his doctor at MedStar Health, in McLean, have begun using the latest technology — adaptive deep brain stimulation — in his ...

More than 10 million people globally live with Parkinson’s disease, for which there is currently no cure. Deep brain stimulation (DBS) is a surgical treatment that helps alleviate some movement ...

At 40, Keith Krehbiel was a successful political scientist with a distinguished professorship, an award-winning book and a membership at the American Academy of Arts and Sciences. But he also was ...

For decades, Keith Krehbiel took high doses of medications with a debilitating side effect—severe nausea—following his diagnosis with early-onset Parkinson’s disease at age 42 in 1997. When each dose ...

Medtronic has won FDA approval for a device that can help with therapy for those suffering from Parkinson’s Disease. The Dublin-based company’s BrainSense Adaptive deep brain stimulation (aDBS) and ...

On Monday, the FDA approved Medtronic plc’s (NYSE:MDT) BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s disease. Deep brain ...